AYTU BIOPHARMA INC's ticker is AYTU and the CUSIP is 054754874. A total of 46 filers reported holding AYTU BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $8,806 | -2.2% | 46,593 | 0.0% | 0.00% | – |
| Q3 2022 | $9,000 | -73.5% | 46,593 | -3.2% | 0.00% | – |
| Q2 2022 | $34,000 | -35.8% | 48,132 | -1.0% | 0.00% | – |
| Q1 2022 | $53,000 | -19.7% | 48,632 | -0.4% | 0.00% | – |
| Q4 2021 | $66,000 | -53.2% | 48,843 | -0.5% | 0.00% | – |
| Q3 2021 | $141,000 | -40.3% | 49,090 | +4.3% | 0.00% | – |
| Q2 2021 | $236,000 | -85.4% | 47,061 | -77.9% | 0.00% | – |
| Q1 2021 | $1,620,000 | +452.9% | 213,140 | +335.4% | 0.00% | – |
| Q4 2020 | $293,000 | – | 48,951 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allred Capital Management, LLC | 125,000 | $23,625 | 0.01% |
| Alyeska Investment Group, L.P. | 1,500,000 | $283,500 | 0.00% |
| Renaissance Technologies | 2,140,782 | $405 | 0.00% |
| Affinity Capital Advisors, LLC | 11,415 | $2,157 | 0.00% |
| FEDERATED HERMES, INC. | 4,551 | $860 | 0.00% |
| JANE STREET GROUP, LLC | 91,887 | $17,367 | 0.00% |
| UBS Group AG | 5,218 | $991 | 0.00% |
| NewEdge Advisors, LLC | 435 | $0 | 0.00% |
| PRUDENTIAL FINANCIAL INC | 179,550 | $33,935 | 0.00% |
| IFP Advisors, Inc | 2,200 | $15 | 0.00% |